Venugopal Rao Veeramaneni
Venugopal Rao Veeramaneni publishes mostly in Organic Chemistry, Pharmacology and Molecular Biology, on topics such as Synthesis and biological activity, Synthesis and Reactions of Organic Compounds and Inflammatory mediators and NSAID effects.
- World rank
- #6,950,864 of 7,710,434 ranked researchers
- Rank in India
- #239,379 of 280,097
- Works
- 19
- Citations
- 237
- Citations per work
- 12.5
What does Venugopal Rao Veeramaneni research?
Venugopal Rao Veeramaneni's work is mostly in Chemistry (73%), Medicine (14%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1474.5%
- Chemistry1472.7%
- Engineering01.8%
- Health Sciences314.5%
- Medicine314.5%
- Life Sciences29.1%
- 1Organic Chemistry69% of their works
- 2Pharmacology14% of their works
- 3Molecular Biology7% of their works
- 4Spectroscopy4% of their works
- 5Biomedical Engineering2% of their works
- 6Biochemistry2% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Reactions of Organic Compounds
- Inflammatory mediators and NSAID effects
- Synthesis and Biological Evaluation
- Chemical synthesis and alkaloids
- Asymmetric Synthesis and Catalysis
- Synthesis and Reactivity of Sulfur-Containing Compounds
- Quinazolinone synthesis and applications
Which keywords describe Venugopal Rao Veeramaneni's research?
The keywords of their largest research topics: Synthesis, Heterocyclic Compounds, Medicinal Chemistry, Catalyst, Chemoselective, Heterocycles, Biological Evaluation and Tubulin Inhibitors.
- Thioamides
- Organocatalysis
- Galanthamine
- Amaryllidaceae
- Antimicrobial Activity
- Inflammation
- Cyclooxygenase-2 Inhibitors
- Alkaloids
- Tubulin Inhibitors
- Heterocycles
- Catalyst
- Heterocyclic Compounds
- Synthesis
- Medicinal Chemistry
- Chemoselective
- Biological Evaluation
- Vascular Targeting Agents
- Anticancer
- Imidazoles
- Oxazolones
- Quinoxaline
- Enantioselective Reactions
- Indirubin
- Quinazoline
- Thionation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 25 words, with their numbers
- Synthesis154 topics
- Heterocyclic Compounds112 topics
- Medicinal Chemistry112 topics
- Catalyst92 topics
- Chemoselective82 topics
- Heterocycles82 topics
- Biological Evaluation72 topics
- Tubulin Inhibitors71 topic
- Vascular Targeting Agents71 topic
- Alkaloids62 topics
- Anticancer62 topics
- Cyclooxygenase-2 Inhibitors51 topic
- Imidazoles51 topic
- Inflammation51 topic
- Oxazolones51 topic
- Antimicrobial Activity41 topic
- Quinoxaline41 topic
- Amaryllidaceae31 topic
- Enantioselective Reactions31 topic
- Galanthamine31 topic
- Indirubin31 topic
- Organocatalysis31 topic
- Quinazoline31 topic
- Thioamides31 topic
- Thionation31 topic
Where does Venugopal Rao Veeramaneni work?
Venugopal Rao Veeramaneni's main affiliation in the publication record is Dr. Reddy's Laboratories (India), India.
How many publications and citations does Venugopal Rao Veeramaneni have?
OpenAlex counts 19 works and 237 citations for Venugopal Rao Veeramaneni, an h-index of 8, ranking #6,950,864 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Venugopal Rao Veeramaneni. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.